Role of adipocytokines in insulin resistance: Studies from urban western Indian population

International Journal of Diabetes and Metabolism

Volumn 18, Issue 1, 2010, Pages 35-42

  Mahadik, Sujata R ^a   Deo, Sudha S ^a   Mehtalia, Suresh D ^a  

^a Sir Hurkisondas Nurrotumdas Hospital & Research Centre   (India)

Author keywords

Adipocytokines; Insulin resistance; Urban Indian Population

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; URBAN AREA; WESTERN INDIAN;

EID: 79960141631     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: 10.1159/000497691     Document Type: Article

References (38)

1. Chandalia M, Abate N, Gerg A, Stray-Gunderson J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian Men. J Clin Endocrinol Metab 1999; 84: 2329-2335.
2. Mahadik SR, Deo SS, Mehatalia SD. Increased prevalence of metabolic syndrome in non-obese Asian Indian: An Urban-Rural comparison. Metab Syndr Relat Disord 2007; 5: 142-152.
3. Pittas AG, Joseph NA, Greeberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 2004; 89: 447-452.
4. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BLG, Murhy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: Correlations with insulin resistance. Eur J Endocrinol 2003; 149: 331-335.
5. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006; 55:1537-1545.
6. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-1792.
7. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
8. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: A review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002; 26: 1407-1433.
9. Widjaja A, Shalton ZA, Horn R, Holman RR, Turner R, Brabant G. UKPDS 20: Plasma leptin, obesity and plasma insulin in Type 2 diabetic subjects. J Clin Endocrinol Metab 1997; 82: 654-657.
10. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312.
11. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 2002; 10: 1-5.
12. Nagaev I, Smith U. Insulin resistance and Type 2 diabetes are not related to resistin expression in human fat cell or skeletal muscle. Biochem Biophys Res Commun 2001; 295: 561-564.
13. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003; 11: 997-1001.
14. Sethi JK, Hotamisligil GS. The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 1999; 10: 19-29.
15. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumour necrosis factor and interleukin 6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280: E745-E751.
16. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin 6 in relation to adiposity, insulin action and insulin secretion. Obes Res 2001; 9: 414-417.
17. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentration of a novel, adipose specific protein adiponectin, in Type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
18. Lele RD, Joshi SR, Gupte A. Association of Adipocytokines (Leptin, Adiponectin, TNF alpha), Insulin and Proinsulin with Diabetes: The Mumbai Obesity Project [MOP]. JAPI 2006; 54: 689-696.
19. Girard J. Is leptin the link between obesity and insulin resistance? Diabetes Metab 1997; 23: 16-24.
20. Abdelgadir M, Elbagir M, Eltom M, Berne C, Ahren B. Reduced leptin concentration in subjects with Type 2 diabetes mellitus in Sudan. Metabolism 2002; 51: 304-306.
21. World Health Organization. Definition, diagnosis and classifiation of Diabetes Mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of Diabetes Mellitus (WHO/NCD/CS/99.2) World Health Organization, Geneva. 1999.
22. World Health Organization. The Asia-Pacific perspective: Redefining obesity and its treatment. Geneva, Switzerland: World Health Organization, 2000.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and Beta Cell Function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
24. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.
25. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al. PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose derived protein. Diabetes 2001; 50:2094-2099.
26. Lihn A, Yunk-Wook KK, Bruun J, Pedersen S, Richelsen B. Human in vitro and in vivo effects of thiazoledinediones on adiponectin. Obes Res 2003; 11: A 35
27. Koshiba K, Nomura M, Nakaya Y, Ito S. Efficiency of glimepiride on insulin resistance, adipocytokines, and atherosclerosis. J Med Invest 2006; 53: 87-94.
28. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G. Analysis of paradoxical observation on the association between leptin and insulin resistance. FASEB J 2002; 16: 1163-1176.
29. Marita AR, Sarkar J, Rane S. Type 2 diabetes in nonobese Indian subjects is associated with reduced leptin levels: Study from Mumbai, Western India. Mol Cell Biochem 2005; 275: 143-151.
30. Sayeed MA, Khan AKA., Mahtab HM, Ahsan KA, Banu A, Khanam PA. et al. Leptin is reduced in lean subjects with Type 2 diabetes in Bangladesh. Diabetes Care 2000; 26: 547.
31. Wauters M, Considine RV, Yudkin JS, Peiffer F, De Leeuw I, Van Gaal LF. Leptin levels in insulin resistance and insulin secretion. Horm Metab Res 2003; 35: 92-96.
32. Tatti P, Masselli L, Buonanno A, Di Mauro P, Strollo F. Leptin levels in diabetic and nondiabetic subjects. Endocrine, 2001; 15: 305-308.
33. Al-Harithy RN. Strong association between serum levels of leptin and resistin in non-diabetic Saudi adult women. Kuwait Med J 2007; 39: 31-35.
34. Lord G. Role of Leptin in Immunology. Nutrition Review 2002; 60: (supp) S35-S38.
35. Shamsuzzaman ASM, Winnichi M, Wolk R, Satikava A, Phillips BG, Davison DE, et al. Independent Association between plasma leptin and C-Reactive Protein in healthy humans. Circulation 2004; 109: 2181-2185.
36. Heilbronn LK, Rood J, Janderova L, Albu JB, Kelley DE, Ravussin E et al. Relationship between serum resistin concentration and insulin resistance in nonobese and obese diabetic subjects. J Clin Endocrinol Metab 2004; 89: 1844-1848.
37. Hui-Bing H, Migita K, Mijashita T, Maeda Y, Nakamura M, Yatsuhashi H, et al. Relationship between serum resistin concentration and inflammatory marker in patients with type 2 diabetes mellitus. Metabolism 2006; 55: 1670-1673.
38. Hotamisligil GS, Spiegelman BM. Tumor Necrosis Factor alpha: a key component of the obesity-diabetes link. Diabetes 1994; 43: 1271-1278.